Liftstream is an executive search recruitment company in the life sciences sector
Alnylam Elects Chairman and Board Member
Alnylam Pharmaceuticals, a biopharmaceutical company headquartered in Cambridge, Mass, has named Michael Bonney as Chairman to replace John Clarke who stepped down after 13 years of service. Clarke will remain on the board as a director of the company. Bonny is the current board member and former CEO of Cubist Pharmaceuticals.
Loxo Oncology Expands Leadership Team
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases, Recruitment Market
Tagged Aisling Capital, biopharmaceutical, CFO, Cluster, Corporate Strategy, development, Dov Goldstein, Erivedge, EVP research & Development, executive recrutiment, Genentech, Jacob Van Naarden, Jennifer Low, Loxo Oncology, New York, research, USA, Vic President, Vicuron
Leave a comment
Swedish biotech Oxthera raises $10m for Orphan Drug Development
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged biopharmaceutical, clinical development, finance, funding, Gentium, Jazz Pharma, Kidney Failure in enteric hyperoxaluria, KLS Partners, Kurma Partners, Mayo Clinic, Medicon Valley, Oxabact, Oxazyme, Oxthera, primary hyperoxaluria, Remi Droller, sweden
Leave a comment
NPS Pharma enrols first patient in global registry for Hypoparathyroidism
Authored by James Sheppard
Ipsen secures development platform with Syntaxin Purchase
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Abbingworth, Agromegaly, Allergan, biopharmaceutical, biotechnology, Botox, chronic pain, clinical trials, Dr John Craddock, Dr Keith Foster, Ipsen, J&J Development, Lundbeckfond Ventures, Marc de Garidel, neurology, Oxford Biotech, peptides, platforms, SROne, SXN101959, Syntaxin, toxins
Leave a comment